These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22168566)

  • 21. [Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation].
    Hosonuma R; Fujiwara S; Sasazaki M; Hirata Y; Yamamoto C; Uesawa M; Oh I; Matsuyama T; Mori M; Ozawa K; Muroi K
    Rinsho Ketsueki; 2012 Apr; 53(4):469-71. PubMed ID: 22687983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus 0.1% and granuloma annulare: description of three cases.
    Grieco T; Cantisani C; Faina P; Cantoresi F; Lacobellis F; Silvestri E; Faina V; Calvieri S
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1445-6. PubMed ID: 19470060
    [No Abstract]   [Full Text] [Related]  

  • 23. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
    Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
    Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic demyelinating polyneuropathy secondary to treatment with tacrolimus].
    Rodríguez-Gómez D; Rodríguez-Rodríguez A; Pérez-Carral O; Lustres-Pérez M; Cid-Rodríguez MC
    Rev Neurol; 2008 Feb 1-15; 46(3):189-90. PubMed ID: 18297634
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
    Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
    Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical treatment tacrolimus and food allergy.
    Martin-Munoz MF; Letran Camacho A; de Lucas Laguna R
    Br J Dermatol; 2005 Oct; 153(4):842-3. PubMed ID: 16181473
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug interactions of tacrolimus].
    Sumner ME; Albers S; Schmidt KG; Laws HJ; Läer S
    Med Monatsschr Pharm; 2006 Apr; 29(4):139-41. PubMed ID: 16628963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosaceiform dermatitis associated with topical tacrolimus treatment.
    Fujiwara S; Okubo Y; Irisawa R; Tsuboi R
    J Am Acad Dermatol; 2010 Jun; 62(6):1050-2. PubMed ID: 20466178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus and gingival hyperplasia.
    Basile C; Marangi AL; Montanaro A; Giordano R; De Padova F; Ligorio VA; Santese D; Di Marco L; Semeraro A; Vernaglione L
    Nephrol Dial Transplant; 1998 Nov; 13(11):2980-1. PubMed ID: 9829526
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sporotrichosis].
    Ito A
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):378-80. PubMed ID: 10201230
    [No Abstract]   [Full Text] [Related]  

  • 31. Disseminated cutaneous sporotrichosis associated with anergic immuno-suppression due to miliary tuberculosis.
    Addy JH
    West Afr J Med; 1992; 11(3):216-20. PubMed ID: 1476967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tacrolimus and hypertrophic cardiomyopathy].
    Romero E; Hevia S; Castellanos D; Simarro C
    Med Clin (Barc); 1998 Jun; 110(20):804-5. PubMed ID: 9666425
    [No Abstract]   [Full Text] [Related]  

  • 33. Images in clinical medicine. Tacrolimus ointment, alcohol, and facial flushing.
    Lübbe J; Milingou M
    N Engl J Med; 2004 Dec; 351(26):2740. PubMed ID: 15616208
    [No Abstract]   [Full Text] [Related]  

  • 34. Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen.
    Kessler L; Lucescu C; Pinget M; Charton MN; Mutschler V; Wolf P; Berney T; Benhamou PY;
    Transplantation; 2006 Feb; 81(4):636-7. PubMed ID: 16495816
    [No Abstract]   [Full Text] [Related]  

  • 35. Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus.
    Fricain JC; Sibaud V; Campana F; Lepreux S; Taïeb A
    Dermatology; 2005; 210(3):229-32. PubMed ID: 15785053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumefactive demyelination, an uncommon form of tacrolimus neurotoxicity.
    Kim SH; Kim W; Lee KW; Hong EK; Kim HJ
    Neurology; 2011 Feb; 76(7):672-4. PubMed ID: 21321342
    [No Abstract]   [Full Text] [Related]  

  • 37. Facial flush reaction after alcohol ingestion during topical pimecrolimus and tacrolimus treatment.
    Stinco G; Piccirillo F; Sallustio M; Patrone P
    Dermatology; 2009; 218(1):71-2. PubMed ID: 18832812
    [No Abstract]   [Full Text] [Related]  

  • 38. Verruca vulgaris following treatment with tacrolimus ointment.
    Narang T; Pahwa M; Kanwar AJ; Parsad D
    Dermatology; 2006; 213(3):254-5. PubMed ID: 17033184
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrolimus induced subacute cerebellar ataxia.
    Kaleyias J; Faerber E; Kothare SV
    Eur J Paediatr Neurol; 2006 Mar; 10(2):86-9. PubMed ID: 16530436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.